Ryota Tomioka

14:10 Yu-Ju Chen
Mapping Nanoscale-to-Single Cell Proteome Landscape and Beyond towards Precision Oncology
14:25 Peter Hoffmann
Prognostic MALDI-MSI: Predicting Chemotherapy Responses and Identifying Metastasis in Gynecological Cancers
14:40 Jake Violi
Proteome-Wide Degron Screening
14:55 Ilisia Ow
Specific Enhancement of Neoantigen Presentation by Targeted Proteasomal Degradation
15:10 Ryota Tomioka
Advancing Bottom-up Proteomics with Protease Type XIII from Aspergillus saitoi

Organized by Yasushi Ishihama (Kyoto University, Japan) and Jun Adachi (National Institutes of Biomedical Innovation, Health and Nutrition, Japan)
In recent years, mass spectrometry-based omics technologies have become significantly more sensitive and faster. We will discuss the impact of these advances on clinical omics analysis, biomarker development, and treatment development through cutting-edge research presentations.